Description
The global non-invasive prenatal testing market was valued at USD 5,088.6 Million in 2025, and is projected to reach USD 9,853.3 Million by 2032. Non-invasive prenatal testing (NIPT) is an advanced prenatal screening method used to evaluate the risk of fetal genetic abnormalities through the analysis of cell-free fetal DNA (cfDNA) present in maternal blood. The test is primarily used to detect chromosomal abnormalities such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), and sex chromosome aneuploidies. Compared with conventional invasive procedures such as amniocentesis and chorionic villus sampling (CVS), NIPT offers a safer and highly accurate alternative with minimal risk of miscarriage and the ability to perform testing as early as 9–10 weeks of pregnancy.
The market growth is being driven by the rising prevalence of chromosomal and genetic disorders, increasing maternal age, and growing awareness regarding early prenatal screening. In addition, the rapid expansion of NIPT applications beyond common trisomies, including microdeletions and rare genetic conditions, is further supporting market demand. The increasing preference for non-invasive diagnostic techniques, coupled with favorable reimbursement policies and government support for prenatal screening programs in several countries, is also contributing significantly to the expansion of the global NIPT market.
Key Highlights of the Report
• In terms of product, consumables & reagents dominate the global non-invasive prenatal testing (NIPT) market, driven by their indispensable and recurring use across every test performed.
• The instruments segment accounted for over a quarter share of the global non-invasive prenatal testing (NIPT) market in 2025, supported by increasing adoption of advanced sequencing platforms and automated systems.
• By gestation period, the 13–24 weeks gestation segment dominated the global non-invasive prenatal testing (NIPT) market in 2025, as it represents the most commonly utilized window for prenatal screening. This timeframe provides an optimal balance between sufficient fetal DNA availability and high diagnostic accuracy, making it the preferred stage for NIPT adoption.
• The 0–12 weeks gestation segment is emerging as the fastest-growing phase in the global non-invasive prenatal testing (NIPT) market, driven by increasing demand for early risk assessment.
• The 25–36 weeks gestation segment accounted for a comparatively smaller share of the market in 2025, as it is primarily used for late-stage or follow-up testing.
• Based on pregnancy risk, the high & average risk pregnancy segment dominated the global non-invasive prenatal testing (NIPT) market in 2025, driven by strong clinical reliance and well-established screening guidelines.
• The low-risk pregnancy segment is emerging as the fastest-growing category in the global non-invasive prenatal testing (NIPT) market.
• In terms of technology, Next-Generation Sequencing (NGS) is the leading technology in the global non-invasive prenatal testing (NIPT) market. NGS platforms support scalable, high-throughput workflows, making them well-suited for large diagnostic laboratories and centralized testing models.
• The array technology segment is mainly applied in targeted use cases, particularly for the detection of sub-chromosomal abnormalities and copy number variations.
• The polymerase chain reaction (PCR) segment is projected to record the fastest growth within the technology landscape. This growth is supported by its cost-effectiveness, rapid turnaround time, and suitability for targeted screening applications.
• By Application, the trisomy detection segment is expected to remain the leading contributor to the global non-invasive prenatal testing (NIPT) market.
• The microdeletion syndrome segment is emerging as the fastest-growing application area in the global non-invasive prenatal testing (NIPT) market. Growth in this segment is being driven by expanding clinical capabilities and rising awareness of rare genetic disorders.
• In terms of end users, the diagnostic laboratories is the leading end-user category in the global non-invasive prenatal testing (NIPT) market. This dominance is primarily attributed to the presence of advanced laboratory infrastructure, high-throughput sequencing technologies, and specialized expertise required for precise genetic analysis.
• The hospitals & clinics segment is driven by the increasing integration of NIPT into routine prenatal care practices. Hospitals and clinics act as the primary point of patient interaction, providing direct access to testing services, genetic counselling, and comprehensive pregnancy management.
• By region, North America dominates the global non-invasive prenatal testing (NIPT) market, primarily driven by the region’s advanced healthcare infrastructure and early adoption of genomic and molecular diagnostic technologies.
• In Europe, key countries such as Germany, the United Kingdom, and France lead regional adoption due to structured prenatal screening programs and favorable reimbursement policies in certain markets.
• Asia Pacific is projected to be the fastest-growing regional market, driven by rising healthcare investments, increasing maternal age, and expanding awareness of prenatal screening across the region.
Apelo Consulting report titled “Global Non-Invasive Prenatal Testing Market, Segment Analysis, Key Company Share Profiles, Market Dynamics and Recent Developments – Forecast to 2032” provides a complete assessment of the fast–evolving, high–growth Global Non-Invasive Prenatal Testing Market landscape.
This 104 Pages report with 44 Figures and 14 Tables has been analyzed from 12 pointers:
1) Global – Non-Invasive Prenatal Testing Market and Forecast
2) Global – Non-Invasive Prenatal Testing Market Share and Forecast
3) By Product – Global Non-Invasive Prenatal Testing Market and Forecast
4) By Gestation Period – Global Non-Invasive Prenatal Testing Market and Forecast
5) By Pregnancy Risk – Global Non-Invasive Prenatal Testing Market and Forecast
6) By Technology – Global Non-Invasive Prenatal Testing Market and Forecast
7) By Application – Global Non-Invasive Prenatal Testing Market and Forecast
8) By End User – Global Non-Invasive Prenatal Testing Market and Forecast
9) By Region – Global Non-Invasive Prenatal Testing Market and Forecast
10) Global Non-Invasive Prenatal Testing Market – Company Profiles
11) Global Non-Invasive Prenatal Testing Market – Recent Developments
12) Global Non-Invasive Prenatal Testing – Market Dynamics
Global Non-Invasive Prenatal Testing Market – By Product
1. Consumables & Reagents
2. Instruments
Global Non-Invasive Prenatal Testing Market – By Gestation Period
1. 0-12 Weeks
2. 13-24 Weeks
3. 25-36 Weeks
Global Non-Invasive Prenatal Testing Market – By Pregnancy Risk
1. High & Average Risk
2. Low Risk
Global Non-Invasive Prenatal Testing Market – By Technology
1. NGS
2. Array Technology
3. PCR
4. Others
Global Non-Invasive Prenatal Testing Market – By Application
1. Trisomy Detection
2. Microdeletion Syndrome
3. Others
Global Non-Invasive Prenatal Testing Market – By End User
1. Diagnostic Laboratories
2. Hospitals & Clinics
Global Non-Invasive Prenatal Testing Market – By Region
1. North America
2. Europe
3. Asia-Pacific
4. Latin America
5. Middle East & Africa
Global Non-Invasive Prenatal Testing Market – Company Profiles
1. BillionToOne, Inc.
2. Revvity, Inc.
3. Illumina, Inc.
4. Natera, Inc.
5. Qiagen N.V.
6. Labcorp Holdings Inc.
7. Eurofins Scientific SE
8. Apollo Hospitals Enterprise Limited
9. BGI Genomics Co., Ltd.
10. IHH Healthcare Berhad
Data Source
Apelo Consulting employs comprehensive primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by Apelo Consulting dedicated team of qualified professionals with deep industry experience and expertise.
1. Executive Summary
2. Research Methodology
3. Global – Non-Invasive Prenatal Testing Market and Forecast (2021 – 2032)
4. Global – Non-Invasive Prenatal Testing Market Share and Forecast (2021 – 2032)
4.1 By Product – Non-Invasive Prenatal Testing Market Share and Forecast
4.2 By Gestation Period – Non-Invasive Prenatal Testing Market Share and Forecast (2021 – 2032)
4.3 By Pregnancy Risk – Non-Invasive Prenatal Testing Market Share and Forecast (2021 – 2032)
4.4 By Technology – Non-Invasive Prenatal Testing Market Share and Forecast (2021 – 2032)
4.5 By Application – Non-Invasive Prenatal Testing Market Share and Forecast (2021 – 2032)
4.6 By End User – Non-Invasive Prenatal Testing Market Share and Forecast (2021 – 2032)
4.7 By Region – Non-Invasive Prenatal Testing Market Share and Forecast (2021 – 2032)
5. By Product – Global Non-Invasive Prenatal Testing Market and Forecast (2021 – 2032)
5.1 Global Non-Invasive Prenatal Testing – Consumables & Reagents Market and Forecast
5.2 Global Non-Invasive Prenatal Testing – Instruments Market and Forecast
6. By Gestation Period – Global Non-Invasive Prenatal Testing Market and Forecast (2021 – 2032)
6.1 Global Non-Invasive Prenatal Testing – (0-12) Weeks Market and Forecast
6.2 Global Non-Invasive Prenatal Testing – (13-24) Weeks Market and Forecast
6.3 Global Non-Invasive Prenatal Testing – (25-36) Weeks Market and Forecast
7. By Pregnancy Risk – Global Non-Invasive Prenatal Testing Market and Forecast (2021 – 2032)
7.1 Global Non-Invasive Prenatal Testing – High & Average Risk Market and Forecast
7.2 Global Non-Invasive Prenatal Testing – Low Risk Market and Forecast
8. By Technology – Global Non-Invasive Prenatal Testing Market and Forecast (2021 – 2032)
8.1 Global Non-Invasive Prenatal Testing – NGS Market and Forecast
8.2 Global Non-Invasive Prenatal Testing – Array Technology Market and Forecast
8.3 Global Non-Invasive Prenatal Testing – PCR Market and Forecast
8.4 Global Non-Invasive Prenatal Testing – Others Market and Forecast
9. By Application – Global Non-Invasive Prenatal Testing Market and Forecast (2021 – 2032)
9.1 Global Non-Invasive Prenatal Testing – Trisomy Detection Market and Forecast
9.2 Global Non-Invasive Prenatal Testing – Microdeletion Syndrome Market and Forecast
9.3 Global Non-Invasive Prenatal Testing – Others Market and Forecast
10. By End User – Global Non-Invasive Prenatal Testing Market and Forecast (2021 – 2032)
10.1 Global Non-Invasive Prenatal Testing – Diagnostic Laboratories Market and Forecast
10.2 Global Non-Invasive Prenatal Testing – Hospitals & Clinics Market and Forecast
11. By Region – Non-Invasive Prenatal Testing Market and Forecast (2021 – 2032)
11.1 North America – Non-Invasive Prenatal Testing Market and Forecast
11.2 Europe – Non-Invasive Prenatal Testing Market and Forecast
11.3 Asia Pacific – Non-Invasive Prenatal Testing Market and Forecast
11.4 Latin America – Non-Invasive Prenatal Testing Market and Forecast
11.5 Middle East & Africa – Non-Invasive Prenatal Testing Market and Forecast
12. Global Non-Invasive Prenatal Testing Market – Company Profiles
12.1 BillionToOne, Inc.
12.2 Revvity, Inc.
12.3 Illumina, Inc.
12.4 Natera, Inc.
12.5 Qiagen N.V.
12.6 Labcorp Holdings Inc.
12.7 Eurofins Scientific SE
12.8 Apollo Hospitals Enterprise Limited
12.9 BGI Genomics Co., Ltd.
12.10 IHH Healthcare Berhad
13. Global Non-Invasive Prenatal Testing – Recent Developments
14. Global Non-Invasive Prenatal Testing – Market Dynamics
14.1 Global Non-Invasive Prenatal Testing Market – Growth Drivers
14.2 Global Non-Invasive Prenatal Testing Market – Challenges
List of Figures:
Figure 3-1: Global – Non-Invasive Prenatal Testing Market (Million USD), 2021 - 2025
Figure 3-2: Global – Forecast for Non-Invasive Prenatal Testing Market (Million USD), 2026 – 2032
Figure 5-1: Global Non-Invasive Prenatal Testing – Consumables & Reagents Market (Million USD), 2021 - 2025
Figure 5-2: Global Non-Invasive Prenatal Testing – Forecast for Consumables & Reagents Market (Million USD), 2026 - 2032
Figure 5-3: Global Non-Invasive Prenatal Testing – Instruments Market (Million USD), 2021 - 2025
Figure 5-4: Global Non-Invasive Prenatal Testing – Forecast for Instruments Market (Million USD), 2026 - 2032
Figure 6-1: Global Non-Invasive Prenatal Testing – (0-12) Weeks Market (Million USD), 2021 - 2025
Figure 6-2: Global Non-Invasive Prenatal Testing – Forecast for (0-12) Weeks Market (Million USD), 2026 - 2032
Figure 6-3: Global Non-Invasive Prenatal Testing – (13-24) Weeks Market (Million USD), 2021 - 2025
Figure 6-4: Global Non-Invasive Prenatal Testing – Forecast for (13-24) Weeks Market (Million USD), 2026 - 2032
Figure 6-5: Global Non-Invasive Prenatal Testing – (25-36) Weeks Market (Million USD), 2021 - 2025
Figure 6-6: Global Non-Invasive Prenatal Testing – Forecast for (25-36) Weeks Market (Million USD), 2026 - 2032
Figure 7-1: Global Non-Invasive Prenatal Testing – High & Average Risk Market (Million USD), 2021 - 2025
Figure 7-2: Global Non-Invasive Prenatal Testing – Forecast for High & Average Risk Market (Million USD), 2026 - 2032
Figure 7-3: Global Non-Invasive Prenatal Testing – Low-Risk Market (Million USD), 2021 - 2025
Figure 7-4: Global Non-Invasive Prenatal Testing – Forecast for Low-Risk Market (Million USD),
Figure 8-1: Global Non-Invasive Prenatal Testing – NGS Market (Million USD), 2021 - 2025
Figure 8-2: Global Non-Invasive Prenatal Testing – Forecast for NGS Market (Million USD), 2026 - 2032
Figure 8-3: Global Non-Invasive Prenatal Testing – Array Technology Market (Million USD), 2021 - 2025
Figure 8-4: Global Non-Invasive Prenatal Testing – Forecast for Array Technology Market (Million USD), 2026 - 2032
Figure 8-5: Global Non-Invasive Prenatal Testing – PCR Market (Million USD), 2021 - 2025
Figure 8-6: Global Non-Invasive Prenatal Testing – Forecast for PCR Market (Million USD), 2026 - 2032
Figure 8-7: Global Non-Invasive Prenatal Testing – Others Market (Million USD), 2021 - 2025
Figure 8-8: Global Non-Invasive Prenatal Testing – Forecast for Others Market (Million USD), 2026 - 2032
Figure 9-1: Global Non-Invasive Prenatal Testing – Trisomy Detection Market (Million USD), 2021 - 2025
Figure 9-2: Global Non-Invasive Prenatal Testing – Forecast for Trisomy Detection Market (Million USD), 2026 - 2032
Figure 9-3: Global Non-Invasive Prenatal Testing – Microdeletion Syndrome Market (Million USD), 2021 - 2025
Figure 9-4: Global Non-Invasive Prenatal Testing – Forecast for Microdeletion Syndrome Market (Million USD), 2026 - 2032
Figure 9-5: Global Non-Invasive Prenatal Testing – Others Market (Million USD), 2021 - 2025
Figure 9-6: Global Non-Invasive Prenatal Testing – Forecast for Others Market (Million USD), 2026 - 2032
Figure 10-1: Global Non-Invasive Prenatal Testing – Diagnostic Laboratories Market (Million USD), 2021 - 2025
Figure 10-2: Global Non-Invasive Prenatal Testing – Forecast for Diagnostic Laboratories Market (Million USD), 2026 - 2032
Figure 10-3: Global Non-Invasive Prenatal Testing – Hospitals & Clinics Market (Million USD), 2021 - 2025
Figure 10-4: Global Non-Invasive Prenatal Testing – Forecast for Hospitals & Clinics Market (Million USD), 2026 - 2032
Figure 11-1: North America – Non-Invasive Prenatal Testing Market (Million USD), 2021 – 2025
Figure 11-2: North America – Forecast for Non-Invasive Prenatal Testing Market (Million USD), 2026 - 2032
Figure 11-3: Europe – Non-Invasive Prenatal Testing Market (Million USD), 2021 - 2025
Figure 11-4: Europe – Forecast for Non-Invasive Prenatal Testing Market (Million USD), 2026 - 2032
Figure 11-5: Asia Pacific – Non-Invasive Prenatal Testing Market (Million USD), 2021 - 2025
Figure 11-6: Asia Pacific – Forecast for Non-Invasive Prenatal Testing Market (Million USD), 2026 - 2032
Figure 11-7: Latin America – Non-Invasive Prenatal Testing Market (Million USD), 2021 - 2025
Figure 11-8: Latin America – Forecast for Non-Invasive Prenatal Testing Market (Million USD), 2026 - 2032
Figure 11-9: Middle East & Africa – Non-Invasive Prenatal Testing Market (Million USD), 2021 - 2025
Figure 11-10: Middle East & Africa – Forecast for Non-Invasive Prenatal Testing Market (Million USD), 2026 - 2032
List of Tables:
Table 4-1: By Product – Non-Invasive Prenatal Testing Market Share (Percent), 2021 – 2025
Table 4-2: By Product – Forecast for Non-Invasive Prenatal Testing Market Share (Percent), 2026-2032
Table 4-3: By Gestation Period – Non-Invasive Prenatal Testing Market Share (Percent), 2021 – 2025
Table 4-4: By Gestation Period – Forecast for Non-Invasive Prenatal Testing Market Share (Percent), 2026 - 2032
Table 4-5: By Pregnancy Risk – Non-Invasive Prenatal Testing Market Share (Percent), 2021 – 2025
Table 4-6: By Pregnancy Risk – Forecast for Non-Invasive Prenatal Testing Market Share (Percent), 2026 - 2032
Table 4-7: By Technology – Non-Invasive Prenatal Testing Market Share (Percent), 2021 – 2025
Table 4-8: By Technology - Forecast for Non-Invasive Prenatal Testing Market Share (Percent), 2026 - 2032
Table 4-9: By Application – Non-Invasive Prenatal Testing Market Share (Percent), 2021 – 2025
Table 4-10: By Application - Forecast for Non-Invasive Prenatal Testing Market Share (Percent), 2026 - 2032
Table 4-11: By End User – Non-Invasive Prenatal Testing Market Share (Percent), 2021 – 2025
Table 4-12: By End User – Forecast for Non-Invasive Prenatal Testing Market Share (Percent), 2026 - 2032
Table 4-13: By Region – Non-Invasive Prenatal Testing Market Share (Percent), 2021 – 2025
Table 4-14: By Region – Forecast for Non-Invasive Prenatal Testing Market Share (Percent), 2026 - 2032
Global Non-Invasive Prenatal Testing Market – By Product
1. Consumables & Reagents
2. Instruments
Global Non-Invasive Prenatal Testing Market – By Gestation Period
1. 0-12 Weeks
2. 13-24 Weeks
3. 25-36 Weeks
Global Non-Invasive Prenatal Testing Market – By Pregnancy Risk
1. High & Average Risk
2. Low Risk
Global Non-Invasive Prenatal Testing Market – By Technology
1. NGS
2. Array Technology
3. PCR
4. Others
Global Non-Invasive Prenatal Testing Market – By Application
1. Trisomy Detection
2. Microdeletion Syndrome
3. Others
Global Non-Invasive Prenatal Testing Market – By End User
1. Diagnostic Laboratories
2. Hospitals & Clinics
Global Non-Invasive Prenatal Testing Market – By Region
1. North America
2. Europe
3. Asia-Pacific
4. Latin America
5. Middle East & Africa
